Tuberculosis and serious infusion reactions in Japanese patients with rheumatoid arthritis: Results from the post marketing surveillance trial.

被引：0
|
作者：
Dabbous, Omar
Tatsuki, Yoshihiko
Rahman, Mirza I.
Gilmer, Keith
Arjunji, Ramesh
Thompson, Heidi
Togo, Masanori
Tang, Boxiong
Suzuki, Toshikazu
机构：
[1] Tanabe Seiyaku Co Ltd, Osaka, Japan
[2] Centocor Inc, Horsham, PA USA
来源：
ARTHRITIS AND RHEUMATISM | 2006年 / 54卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S422 / S422
页数：1
相关论文
共 50 条
  • [21] 24-week, Post-Marketing Surveillance Analysis of Upadacitinib in Japanese Patients with Rheumatoid Arthritis: The 2024 Interim Report
    Fujii, Takao
    Okamoto, Nami
    Abe, Asami
    Takagi, Michiaki
    Takahashi, Nobunori
    Nakajima, Atsuo
    Nakajima, Ayako
    Nakayamada, Shingo
    Nishida, Keiichiro
    Kawaberi, Takeshi
    Sunaga, Naomi
    Tsujita, Yuki
    Chonan, Sumi
    Kuwana, Masataka
    Tanaka, Yoshiya
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 1026 - 1029
  • [22] Safety and effectiveness of sarilumab in Japanese patients with rheumatoid arthritis refractory to previous treatments: An interim analysis of a post-marketing surveillance
    Kameda, Hideto
    Tasaka, Sadatomo
    Takahashi, Toshiya
    Suzuki, Katsuhisa
    Soeda, Naoki
    Tanaka, Yoshiya
    MODERN RHEUMATOLOGY, 2024, 34 (03) : 444 - 452
  • [23] Malignancy in Japanese Patients with Rheumatoid Arthritis Treated with Tofacitinib: Interim Analysis of All-Case Post-Marketing Surveillance
    Tamura, Naoto
    Kuwana, Masataka
    Atsumi, Tatsuya
    Takei, Syuji
    Harigai, Masayoshi
    Fujii, Takao
    Matsuno, Hiroaki
    Mimori, Tsuneyo
    Momohara, Shigeki
    Yamamoto, Kazuhiko
    Takasaki, Yoshinari
    Nomura, Kazuto
    Endo, Yutaka
    Hirose, Tomohiro
    Morishima, Yosuke
    Sugiyama, Naonobu
    Yoshii, Noritoshi
    Takagi, Michiaki
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [24] Correction to: Effect of Golimumab Dose Escalation in Japanese Patients With Rheumatoid Arthritis: Post-Hoc Analysis of Post-Marketing Surveillance Data
    Hirohito Shimizu
    Hisanori Kobayashi
    Masayoshi Kanbori
    Yutaka Ishii
    Rheumatology and Therapy, 2020, 7 : 1053 - 1053
  • [25] SAFETY OF BARICITINIB IN JAPANESE PATIENTS WITH RHEUMATOID ARTHRITIS (RA): THE 2020 INTERIM REPORT FROM ALL-CASE POST MARKETING SURVEILLANCE IN CLINICAL PRACTICE
    Fujii, T.
    Atsumi, T.
    Okamoto, N.
    Takahashi, N.
    Tamura, N.
    Nakajima, A.
    Matsuno, H.
    Tsujimoto, N.
    Nishikawa, A.
    Ishii, T.
    Takeuchi, T.
    Kuwana, M.
    Takagi, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1150 - 1150
  • [26] Safety of Baricitinib in Japanese Patients with Rheumatoid Arthritis (RA): The 2020 Interim Report from All-case Post Marketing Surveillance in Clinical Practice
    Fujii, Takao
    Atsumi, Tatsuya
    Okamoto, Nami
    Takahashi, Nobunori
    Tamura, Naoto
    Nakajima, Atsuo
    Nakajima, Ayako
    Matsuno, Hiroaki
    Tsujimoto, Naoto
    Nishikawa, Atsushi
    Ishii, Taeko
    Takeuchi, Tsutomu
    Kuwana, Masataka
    Takagi, Michiaki
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 3489 - 3490
  • [27] Safety of baricitinib in Japanese patients with rheumatoid arthritis: the 2020 interim report from all-case post-marketing surveillance in clinical practice
    Fujii, T.
    Atsumi, T.
    Okamoto, N.
    Takahashi, N. T. N.
    Tamura, N.
    Nakajima, A.
    Matsuno, H.
    Tsujimoto, N.
    Nishikawa, A.
    Ishii, T.
    Takeuchi, T.
    Kuwana, M.
    Takagi, M.
    Larsson, E.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2021, 50 : 25 - 25
  • [28] SERIOUS INFUSION-RELATED REACTIONS AFTER RITUXIMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS: DATA FROM THE AUTOIMMUNITY AND RITUXIMAB REGISTRY
    Salmon, J. H.
    Ravaud, P.
    Bardin, T.
    Cacoub, P.
    Cantagruel, A.
    Combe, B.
    Dougados, M.
    Flipo, R. -M.
    Godeau, B.
    Guillevin, L.
    Le Loet, X.
    Hachulla, E.
    Schaeverbeke, T.
    Sibilia, J.
    Pane, I.
    Baron, G.
    Mariette, X.
    Gottenberg, J. -E.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 457 - 457
  • [29] Post-Marketing Safety Surveillance of Tofacitinib over 9 Years in Patients with Psoriatic Arthritis and Rheumatoid Arthritis
    Burmester, Gerd R.
    Coates, Laura C.
    Cohen, Stanley B.
    Tanaka, Yoshiya
    Vranic, Ivana
    Nagy, Edward
    Lazariciu, Irina
    Chen, All-shine
    Kwok, Kenneth
    Fallon, Lara
    Kinch, Cassandra
    RHEUMATOLOGY AND THERAPY, 2023, 10 (05) : 1255 - 1276
  • [30] POST-MARKETING SAFETY SURVEILLANCE OF TOFACITINIB OVER 9 YEARS IN PATIENTS WITH RHEUMATOID ARTHRITIS AND PSORIATIC ARTHRITIS
    Burmester, G. R.
    Coates, L.
    Cohen, S. B.
    Tanaka, Y.
    Vranic, I.
    Nagy, E.
    Chen, A. S.
    Lazariciu, I.
    Kwok, K.
    Fallon, L.
    Kinch, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 347 - 348
12345